Signal #114573 · SEC 8-K

$ICU SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $ICU filing catalyst

Why did $ICU trigger an AI stock catalyst alert?

$ICU triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: SeaStar Medical Fulfills FDA Post-Approval Study Requirements for QUELIMMUNE. Key points: - FDA/CBER confirmed post-approval study requirements fulfilled for QUELIMMUNE in pediatric AKI. - Demonstrated statistically significant 90-day survival improvement of 65.1% vs 47.5% control cohort (p=0.043). - De-risks ongoing commercialization under Humanitarian Device Exemption.

How did $ICU stock react after the SEC filing?

After the SEC 8-K for $ICU, observed market reaction: T0 price $2.19. Past moves do not guarantee future results.

Where can I get real-time $ICU SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ICU via Telegram and the VIP Web Terminal from €10/month.

$ICU

$ICU – SeaStar Medical Fulfills FDA Post-Approval Study Requirements for QUELIMMUNE

SeaStar Medical Holding Corp

2026-11-03 00:00:00 UTC · SEC 8-K · All $ICU

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

FDA/CBER confirmed post-approval study requirements fulfilled for QUELIMMUNE in pediatric AKI.
Demonstrated statistically significant 90-day survival improvement of 65.1% vs 47.5% control cohort (p=0.043).
De-risks ongoing commercialization under Humanitarian Device Exemption.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →